MARKET

SPRB

SPRB

Spruce Biosciences, Inc.
NASDAQ
48.19
-0.83
-1.69%
Opening 09:51 09/25 EDT
OPEN
49.22
PREV CLOSE
49.02
HIGH
49.31
LOW
48.19
VOLUME
4.28K
TURNOVER
--
52 WEEK HIGH
240.00
52 WEEK LOW
7.26
MARKET CAP
138.50M
P/E (TTM)
-1.1616
1D
5D
1M
3M
1Y
5Y
1D
Spruce Biosciences Price Target Maintained With a $144.00/Share by Citizens
Dow Jones · 1d ago
Citizens Reiterates Market Outperform on Spruce Biosciences, Maintains $144 Price Target
Benzinga · 1d ago
Weekly Report: what happened at SPRB last week (0914-0918)?
Weekly Report · 4d ago
Lake Street Initiates Coverage of Spruce Biosciences at Buy
NASDAQ · 09/18 00:43
Spruce Biosciences management to meet virtually with B. Riley
TipRanks · 09/17 15:55
Lake Street Initiates Coverage On Spruce Biosciences with Buy Rating, Announces Price Target of $149
Benzinga · 09/17 15:06
Spruce Biosciences Price Target Announced at $149.00/Share by Lake Street
Dow Jones · 09/17 15:04
Spruce Biosciences initiated with a Buy at Lake Street
TipRanks · 09/17 11:50
More
About SPRB
Spruce Biosciences, Inc. is a biopharmaceutical company focused on developing and commercializing therapies for neurological disorders with significant unmet medical need. It has a diverse portfolio of product candidates addressing diseases with high unmet medical need and clear biology for treatment, for which there are either no approved therapies treating the underlying disease or suboptimal treatment options. Its pipeline consists of TA-ERT, Tildacerfont and Cortibon, and SPR202. TA-ERT is a fusion protein comprised of recombinant human alpha-N-acetylglucosaminidase. TA-ERT is intended as an enzyme replacement therapy for the treatment of patients with MPS IIIB who lack rhNAGLU enzyme activity. Tildacerfont has the potential to address hyperactive brain corticotropin-releasing factors neurotransmission and aberrant functioning of the hypothalamus-pituitary-adrenal axis in patients with MDD. SPR202 focuses on the treatment of Congenital Adrenal Hyperplasia and other indications.

Webull offers Spruce Biosciences, Inc stock information, including NASDAQ: SPRB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SPRB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SPRB stock methods without spending real money on the virtual paper trading platform.